{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:01Z","timestamp":1793381281260,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalradiologyonline.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.crad.2025.106833","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T01:50:55Z","timestamp":1738288255000},"page":"106833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Advancing personalised care in ovarian cancer using CT and MRI radiomics"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-6816","authenticated-orcid":false,"given":"S.","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-2738","authenticated-orcid":false,"given":"S.","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-1480","authenticated-orcid":false,"given":"N.","family":"Bharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8270-5597","authenticated-orcid":false,"given":"A.","family":"Rockall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2025.106833_bib1","article-title":"Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: implications for surgical and clinical outcomes","volume":"4","author":"Cunnea","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.crad.2025.106833_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"New England J Med"},{"key":"10.1016\/j.crad.2025.106833_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.canlet.2019.02.054","article-title":"Differentiation of glioblastoma from solitary brain metastases using radiomic machine-learning classifiers","volume":"451","author":"Qian","year":"2019","journal-title":"Cancer Lett"},{"key":"10.1016\/j.crad.2025.106833_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fonc.2019.00505","article-title":"Machine learning-based analysis of MR multiparametric radiomics for the subtype classification of breast cancer","volume":"9","author":"Xie","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00330-020-07119-7","article-title":"Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?","volume":"31","author":"Liu","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib6","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Canc J Clin"},{"key":"10.1016\/j.crad.2025.106833_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/tog.12107","article-title":"TAW, Risk-reducing surgery for women at high risk of epithelial ovarian cancer","volume":"16","author":"Gaughan","year":"2014","journal-title":"Obs Gynaec"},{"key":"10.1016\/j.crad.2025.106833_bib8","article-title":"Epithelial ovarian cancer: review article","volume":"33","author":"Sambasivan","year":"2022","journal-title":"Canc Treat Res Commun"},{"key":"10.1016\/j.crad.2025.106833_bib10","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/s00330-016-4600-3","article-title":"ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update","volume":"27","author":"Forstner","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.19896","article-title":"Ovarian-adnexal reporting data System magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses","volume":"3","author":"Thomassin-Naggara","year":"2020","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.crad.2025.106833_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63369-1","article-title":"Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer","volume":"14","author":"Leng","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2025.106833_bib13","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1007\/s00330-024-10817-1","article-title":"ESR Essentials: characterisation and staging of adnexal masses with MRI and CT\u2014practice recommendations by ESUR","volume":"34","author":"Avesani","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"Du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.crad.2025.106833_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of Debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer","volume":"332","author":"Van Der Burg","year":"1995","journal-title":"New England J Med"},{"key":"10.1016\/j.crad.2025.106833_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"New England J Med"},{"key":"10.1016\/j.crad.2025.106833_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41416-021-01662-w","article-title":"Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC)","volume":"126","author":"Fotopoulou","year":"2022","journal-title":"British J Canc"},{"key":"10.1016\/j.crad.2025.106833_bib18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2016.71.0723","article-title":"Value of neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer: a European perspective","volume":"35","author":"Fotopoulou","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104628","article-title":"Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images","volume":"25","author":"Hu","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.crad.2025.106833_bib20","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.acra.2022.06.007","article-title":"Discriminating between benign and malignant solid ovarian tumors based on clinical and radiomic features of MRI","volume":"30","author":"Zheng","year":"2023","journal-title":"Acad Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-019-08718-9","article-title":"A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer","volume":"10","author":"Lu","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.crad.2025.106833_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.868265","article-title":"Clinically interpretable radiomics-based prediction of histopathologic response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma","volume":"12","author":"Rundo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib23","article-title":"Machine-learning-based contrast-enhanced computed tomography radiomic analysis for categorization of ovarian tumors","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib24","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1038\/s41598-021-87775-x","article-title":"A radiomics approach for automated diagnosis of ovarian neoplasm malignancy in computed tomography","volume":"11","author":"Li","year":"2021","journal-title":"Scient Rep"},{"key":"10.1016\/j.crad.2025.106833_bib25","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","article-title":"Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study","volume":"29","author":"Zhang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib26","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1007\/s00330-020-07266-x","article-title":"Evaluation of a convolutional neural network for ovarian tumor differentiation based on magnetic resonance imaging","volume":"31","author":"Wang","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072106","article-title":"Manifestations of ovarian cancer in relation to other pelvic diseases by MRI","volume":"15","author":"Bourgioti","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2025.106833_bib28","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/annonc\/mdw090","article-title":"Management of borderline ovarian tumors","volume":"27","author":"Du Bois","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib29","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1200\/JCO.2001.19.10.2658","article-title":"Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study","volume":"19","author":"Zanetta","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2019.12.046","article-title":"Fertility and prognosis of borderline ovarian tumor after conservative management: results of the multicentric OPTIBOT study by the GINECO & TMRG group","volume":"157","author":"Chevrot","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib31","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.ejca.2013.01.035","article-title":"Borderline tumours of the ovary: a cohort study of the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie (AGO) study group","volume":"49","author":"du Bois","year":"2013","journal-title":"Eur J Canc"},{"key":"10.1016\/j.crad.2025.106833_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.7334","article-title":"Use of ultrasound pattern recognition by expert operators to identify borderline ovarian tumors: a study of diagnostic performance and interobserver agreement","volume":"35","author":"Yazbek","year":"2010","journal-title":"Ultrasound Obstetr Gynecol"},{"key":"10.1016\/j.crad.2025.106833_bib33","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1148\/rg.220068","article-title":"MRI of borderline epithelial ovarian tumors: pathologic correlation and diagnostic challenges","volume":"42","author":"Tsuboyama","year":"2022","journal-title":"RadioGraphics"},{"key":"10.1016\/j.crad.2025.106833_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13244-022-01264-x","article-title":"T2-weighted MRI-based radiomics for discriminating between benign and borderline epithelial ovarian tumors: a multicenter study","volume":"13","author":"Wei","year":"2022","journal-title":"Insights Into Imaging"},{"key":"10.1016\/j.crad.2025.106833_bib35","first-page":"329","article-title":"MDCT-based radiomics features for the differentiation of serous borderline ovarian tumors and serous malignant ovarian tumors","volume":"13","author":"Yu","year":"2021","journal-title":"Canc Manag Res"},{"key":"10.1016\/j.crad.2025.106833_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10278-023-00903-z","article-title":"CT-based radiomics and machine learning for differentiating benign, borderline, and early-stage malignant ovarian tumors","volume":"37","author":"Chen","year":"2024","journal-title":"J Imag Inform Med"},{"key":"10.1016\/j.crad.2025.106833_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00330-020-07112-0","article-title":"Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms","volume":"31","author":"Song","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45141","article-title":"Computed tomographic radiomics in differentiating histologic subtypes of epithelial ovarian carcinoma","volume":"5","author":"Wang","year":"2022","journal-title":"Jama Network Open"},{"key":"10.1016\/j.crad.2025.106833_bib39","first-page":"151","article-title":"Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.crad.2025.106833_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00330-020-07091-2","article-title":"MR image-based radiomics to differentiate type \u0399 and type \u0399\u0399 epithelial ovarian cancers","volume":"31","author":"Jian","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib41","article-title":"A review of the clinical characteristics and novel molecular subtypes of endometrioid ovarian cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib42","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s11604-024-01545-z","article-title":"Magnetic resonance imaging-based radiomics analysis of the differential diagnosis of ovarian clear cell carcinoma and endometrioid carcinoma: a retrospective study","volume":"42","author":"Takeyama","year":"2024","journal-title":"Jap J Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib43","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s11547-023-01666-x","article-title":"Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer","volume":"128","author":"Ren","year":"2023","journal-title":"La Radiologia Medica"},{"key":"10.1016\/j.crad.2025.106833_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1148\/radiol.2232011081","article-title":"Peritoneal metastases: detection with spiral CT in patients with ovarian cancer","volume":"223","author":"Coakley","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.106833_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s41747-023-00388-z","article-title":"Deep learning-based segmentation of multisite disease in ovarian cancer","volume":"7","author":"Buddenkotte","year":"2023","journal-title":"Eur Radiol Exper"},{"key":"10.1016\/j.crad.2025.106833_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.610742","article-title":"Preoperative prediction of metastasis for ovarian cancer based on computed tomography radiomics features and clinical factors","volume":"11","author":"Ai","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib47","article-title":"The development and validation of a CT-based radiomics nomogram to preoperatively predict lymph node metastasis in high-grade serous ovarian cancer","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib48","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.21037\/qims-22-1135","article-title":"CT-based deep learning segmentation of ovarian cancer and the stability of the extracted radiomics features","volume":"13","author":"Wang","year":"2023","journal-title":"Quant Imag Med Surg"},{"key":"10.1016\/j.crad.2025.106833_bib49","article-title":"End-to-End integrative segmentation and radiomics prognostic models improve risk stratification of high-grade serous ovarian cancer: a retrospective multi-cohort study","author":"Linton-Reid","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.crad.2025.106833_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-021-00941-7","article-title":"MR-based radiomics-clinical nomogram in epithelial ovarian tumor prognosis prediction: tumor body texture analysis across various acquisition protocols","volume":"15","author":"Wang","year":"2022","journal-title":"J Ovar Res"},{"key":"10.1016\/j.crad.2025.106833_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1334062","article-title":"Multitask prediction models for serous ovarian cancer by preoperative CT image assessments based on radiomics","volume":"11","author":"Fu","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.crad.2025.106833_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(20)30591-X","article-title":"Objective responses to first-line neoadjuvant carboplatin\u2013paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial","volume":"22","author":"Morgan","year":"2021","journal-title":"Lanc Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.crad.2025.106833_bib54","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1038\/s41467-023-41820-7","article-title":"Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer","volume":"14","author":"Crispin-Ortuzar","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.crad.2025.106833_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002198","article-title":"Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: a retrospective study","volume":"13","author":"Parkinson","year":"2016","journal-title":"PLOS Med"},{"key":"10.1016\/j.crad.2025.106833_bib56","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2019.11.013","article-title":"Intratumor heterogeneity and homologous recombination deficiency of high-grade serous ovarian cancer are associated with prognosis and molecular subtype and change in treatment course","volume":"156","author":"Takaya","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib57","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1007\/s00261-020-02820-z","article-title":"Radiomics and radiogenomics in ovarian cancer: a literature review","volume":"46","author":"Nougaret","year":"2021","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib58","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"\"Platinum resistant\" ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ijgc-2019-000222","article-title":"Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score","volume":"29","author":"McNulty","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.crad.2025.106833_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1341228","article-title":"Combined radiomics-clinical model to predict platinum-sensitivity in advanced high-grade serous ovarian carcinoma using multimodal MRI","volume":"14","author":"Na","year":"2024","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.crad.2025.106833_bib61","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ygyno.2019.04.679","article-title":"Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual patient data","volume":"154","author":"Cohen","year":"2019","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.crad.2025.106833_bib62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ygyno.2011.12.423","article-title":"Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer","volume":"125","author":"Barlin","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ygyno.2013.04.001","article-title":"Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: a Gynecologic Oncology Group study","volume":"130","author":"Landrum","year":"2013","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.crad.2025.106833_bib64","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47983-z","article-title":"Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer","volume":"13","author":"Mysona","year":"2023","journal-title":"Scientific Reports"},{"key":"10.1016\/j.crad.2025.106833_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/953509","article-title":"Recent advancements in prognostic factors of epithelial ovarian carcinoma","volume":"2014","author":"Ezzati","year":"2014","journal-title":"International Scholarly Research Notices"},{"key":"10.1016\/j.crad.2025.106833_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110018","article-title":"A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer","volume":"145","author":"Chen","year":"2021","journal-title":"European Journal of Radiology"},{"key":"10.1016\/j.crad.2025.106833_bib67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fonc.2019.00255","article-title":"A computed tomography-based radiomic prognostic marker of advanced high-grade serous ovarian cancer recurrence: a multicenter study","volume":"9","author":"Wei","year":"2019","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/j.crad.2025.106833_bib68","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1007\/s00330-018-5389-z","article-title":"Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months","volume":"28","author":"Rizzo","year":"2018","journal-title":"European Radiology"},{"key":"10.1016\/j.crad.2025.106833_bib69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2214\/AJR.20.23195","article-title":"Development of MRI-based radiomics model to predict the risk of recurrence in patients with advanced high-grade serous ovarian carcinoma","volume":"217","author":"Li","year":"2021","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.crad.2025.106833_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111013","article-title":"Incorporating SULF1 polymorphisms in a pretreatment CT-based radiomic model for predicting platinum resistance in ovarian cancer treatment","volume":"133","author":"Yi","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.crad.2025.106833_bib71","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1038\/sj.onc.1210300","article-title":"Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance","volume":"26","author":"Staub","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.crad.2025.106833_bib72","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/1120009X.2021.1913702","article-title":"Rs3802278 in 3\u2019-UTR of SULF1 associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients","volume":"33","author":"Zeng","year":"2021","journal-title":"Journal of Chemotherapy"},{"key":"10.1016\/j.crad.2025.106833_bib73","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3390\/cancers12113403","article-title":"Integrated multi-tumor radio-genomic marker of outcomes in patients with high serous ovarian carcinoma","volume":"12","author":"Veeraraghavan","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.crad.2025.106833_bib74","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00262-019-02385-x","article-title":"Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature","volume":"68","author":"Hinchcliff","year":"2019","journal-title":"Canc Immunol Immunother"},{"key":"10.1016\/j.crad.2025.106833_bib75","article-title":"A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer","volume":"13","author":"Zhan","year":"2023","journal-title":"Scient Rep"},{"key":"10.1016\/j.crad.2025.106833_bib76","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s00261-024-04330-8","article-title":"Role of radiomics as a predictor of disease recurrence in ovarian cancer: a systematic review","volume":"49","author":"\u2019Sullivan","year":"2024","journal-title":"Abdominal Radiol"},{"key":"10.1016\/j.crad.2025.106833_bib77","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: the bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.crad.2025.106833_bib78","first-page":"8","article-title":"METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII","volume":"15","author":"Kocak","year":"2024","journal-title":"Insights Into Imag"},{"key":"10.1016\/j.crad.2025.106833_bib79","first-page":"75","article-title":"CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII","volume":"14","author":"Kocak","year":"2023","journal-title":"Insights Into Imag"},{"key":"10.1016\/j.crad.2025.106833_bib80","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1148\/radiol.2020191145","article-title":"The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping","volume":"295","author":"Zwanenburg","year":"2020","journal-title":"Radiology"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T16:56:08Z","timestamp":1744822568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926025000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":79,"alternative-id":["S0009926025000388"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.106833","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing personalised care in ovarian cancer using CT and MRI radiomics","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.106833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"106833"}}